The article ‘Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition’ [2017; 42 (5): 1847–1856DOI: 10.1159/000479542] by Zhi-Dong Lv, Hai-Bo Wang, Xiang-Ping Liu, Li-Ying Jin, Ruo-Wu Shen, Xin-Gang Wang, Bin Kong, Hui-Li Qu, Fu-Nian Li, Qi-Feng Yang has been retracted by the current and former Publishers and the Editor following the authors’ request.
After publication of this article, the authors contacted the journal regarding their fig- ures published in this article. The authors stated that some of the figures in their article were duplicated from their previously published articles and found that certain images were mis- takenly grouped together and labeled, and requested retraction of the article. We identified partial duplication within Figure 3D between the Control and Scr-shRNA groups. Duplica- tion was identified between Figure 6A of the manuscript and Figure 1A from a previously published article with the same first author [1]. Duplication was identified between Figure 5C of this article Figure 4D in another previously published article with the same first author [2]. Duplication was also identified between Figure 6C of this article and Figure 2C from another previously published article with the same first author [3].
When asked to comment on the above, the corresponding author did not provide the original data for this article and requested retraction of the article. As the concerns raised about the figures cannot be addressed, the article has been retracted. The authors agree with the retraction.
| 1 | Lv ZD, Kong B, Liu XP, Dong Q, Niu HT, Wang YH, Li FN, Wang HB. CXCL12 chemo- kine expression suppresses human breast cancer growth and metastasis in vitro and in vivo. Int J Clin Exp Pathol. 2014 Sep 15;7(10):6671-8. PMID: 25400746; PMCID: PMC4230065. |
| 2 | Lv, Z.-D., Yang, Z.-C., Liu, X.-P., Jin, L.-Y., Dong, Q., Qu, H.-L., Li, F.-N., Kong, B., Sun, J., Zhao, J.-J. and Wang, H.-B. (2016), Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial–mesenchymal transition in triple-negative breast cancer. J. Cell. Mol. Med., 20: 1640-1650.
https://doi.org/10.1111/jcmm.12856 |
| 3 | Lv, Z.-D., Kong, B., Liu, X.-P., Jin, L.-Y., Dong, Q., Li, F.-N. and Wang, H.-B. (2016), miR- 655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer. J. Cell. Mol. Med., 20: 864-873.
https://doi.org/10.1111/jcmm.12770 |